TODENTJ-25-03-2019_TODENTJ-11-420
1553507068
Bentham Open
doi@benthamopen.net
Bentham Open
The Open Dentistry Journal
TODENTJ
1874-2106
07
31
2017
11
1
On the Cellular and Molecular Mechanisms of Drug-Induced Gingival Overgrowth
Albert
Ramírez-Rámiz
Lluís
Brunet-LLobet
Eduard
Lahor-Soler
Jaume
Miranda-Rius
Introduction:
Gingival overgrowth has been linked to multiple factors such as adverse drug effects, inflammation, neoplastic processes, and hereditary gingival fibromatosis. Drug-induced gingival overgrowth is a well-established adverse event. In early stages, this gingival enlargement is usually located in the area of the interdental papilla. Histologically, there is an increase in the different components of the extracellular matrix.
Objective:
The aim of this manuscript is to describe and analyze the different cellular and molecular agents involved in the pathogenesis of Drug-induced gingival overgrowth.
Method:
A literature search of the MEDLINE/PubMed database was conducted to identify the mechanisms involved in the process of drug-induced gingival overgrowth, with the assistance of a research librarian. We present several causal hypotheses and discuss the advances in the understanding of the mechanisms that trigger this gingival alteration.
Results:
In vitro studies have revealed phenotypic cellular changes in keratinocytes and fibroblasts and an increase of the extracellular matrix with collagen and glycosaminoglycans. Drug-induced gingival overgrowth confirms the key role of collagenase and integrins, membrane receptors present in the fibroblasts, due to their involvement in the catabolism of collagen. The three drug categories implicated: calcineuron inhibitors (immunosuppressant drugs), calcium channel blocking agents and anticonvulsant drugs appear to present a multifactorial pathogenesis with a common molecular action: the blockage of the cell membrane in the Ca2+/Na+ ion flow. The alteration of the uptake of cellular folic acid, which depends on the regulated channels of active cationic transport and on passive diffusion, results in a dysfunctional degradation of the connective tissue. Certain intermediate molecules such as cytokines and prostaglandins play a role in this pathological mechanism. The concomitant inflammatory factor encourages the appearance of fibroblasts, which leads to gingival fibrosis. Susceptibility to gingival overgrowth in some fibroblast subpopulations is due to phenotypic variability and genetic polymorphism, as shown by the increase in the synthesis of molecules related to the response of the gingival tissue to inducing drugs. The authors present a diagram depicting various mechanisms involved in the pathogenesis of drug-induced gingival overgrowth.
Conclusion:
Individual predisposition, tissue inflammation, and molecular changes in response to the inducing drug favor the clinical manifestation of gingival overgrowth.
07
31
2017
420
435
TODENTJ-11-420
1
10.2174/crossmark_policy
opendentistryjournal.com
benthamopen.com
true
Peer Reviewed
Single blind
Checked with iThenticate
2017-03-16
2017-05-03
2017-06-05
2017-07-31
https://creativecommons.org/licenses/by/4.0/legalcode
10.2174/1874210601711010420
1553507068
https://opendentistryjournal.com/VOLUME/11/PAGE/420/
-
https://opendentistryjournal.com/contents/volumes/V11/TODENTJ-11-420/TODENTJ-11-420.pdf
-
https://opendentistryjournal.com/contents/volumes/V11/TODENTJ-11-420/TODENTJ-11-420.pdf
-
https://opendentistryjournal.com/contents/volumes/V11/TODENTJ-11-420/TODENTJ-11-420.pdf
-
https://opendentistryjournal.com/contents/volumes/V11/TODENTJ-11-420/TODENTJ-11-420.pdf
-
https://opendentistryjournal.com/contents/volumes/V11/TODENTJ-11-420/TODENTJ-11-420.pdf
-
https://opendentistryjournal.com/contents/volumes/V11/TODENTJ-11-420/TODENTJ-11-420.pdf
-
https://opendentistryjournal.com/contents/volumes/V11/TODENTJ-11-420/TODENTJ-11-420.pdf
-
https://opendentistryjournal.com/contents/volumes/V11/TODENTJ-11-420/TODENTJ-11-420.xml
Drug Saf.
Brunet L.
15
219
1996
10.2165/00002018-199615030-00007
Brunet L, Miranda J, Farré M, Berini L, Mendieta C.
Gingival enlargement induced by drugs.
Drug Saf
1996;
15
(3)
: 219-31.
J. Clin. Periodontol.
Rateitschak-Plüss E.M.
10
237
1983
10.1111/j.1600-051X.1983.tb01272.x
Rateitschak-Plüss EM, Hefti A, Lörtscher R, Thiel G.
Initial observation that cyclosporin-A induces gingival enlargement in man.
J Clin Periodontol
1983;
10
(3)
: 237-46.
G. Ital. Cardiol.
Cucchi G.
15
556
1985
Cucchi G, Giustiniani S, Robustelli F.
Gengivite ipertrofica da verapamil.
G Ital Cardiol
1985;
15
(5)
: 556-7.
J. Periodontol.
Lucas R.M.
56
211
1985
10.1902/jop.1985.56.4.211
Lucas RM, Howell LP, Wall BA.
Nifedipine-induced gingival hyperplasia. A histochemical and ultrastructural study.
J Periodontol
1985;
56
(4)
: 211-5.
Oral Surg. Oral Med. Oral Pathol.
Bowman J.M.
65
183
1988
10.1016/0030-4220(88)90163-6
Bowman JM, Levy BA, Grubb RV.
Gingival overgrowth induced by diltiazem. A case report.
Oral Surg Oral Med Oral Pathol
1988;
65
(2)
: 183-5.
J. Clin. Periodontol.
Katz J.
24
180
1997
10.1111/j.1600-051X.1997.tb00488.x
Katz J, Givol N, Chaushu G, Taicher S, Shemer J.
Vigabatrin-induced gingival overgrowth.
J Clin Periodontol
1997;
24
(3)
: 180-2.
Eur. J. Clin. Invest.
Brunet L.
31
781
2001
10.1046/j.1365-2362.2001.00869.x
Brunet L, Miranda J, Roset P, Berini L, Farré M, Mendieta C.
Prevalence and risk of gingival enlargement in patients treated with anticonvulsant drugs.
Eur J Clin Invest
2001;
31
(9)
: 781-8.
J. Periodontol.
Miranda J.
72
605
2001
10.1902/jop.2001.72.5.605
Miranda J, Brunet L, Roset P, Berini L, Farré M, Mendieta C.
Prevalence and risk of gingival enlargement in patients treated with nifedipine.
J Periodontol
2001;
72
(5)
: 605-11.
J. Clin. Periodontol.
Miranda J.
32
294
2005
10.1111/j.1600-051X.2005.00662.x
Miranda J, Brunet L, Roset P, Berini L, Farré M, Mendieta C.
Prevalence and risk of gingival overgrowth in patients treated with diltiazem or verapamil.
J Clin Periodontol
2005;
32
(3)
: 294-8.
J. Periodontol.
Pernu H.E.
63
548
1992
10.1902/jop.1992.63.6.548
Pernu HE, Pernu LM, Huttunen KR, Nieminen PA, Knuuttila ML.
Gingival overgrowth among renal transplant recipients related to immunosuppressive medication and possible local background factors.
J Periodontol
1992;
63
(6)
: 548-53.
J. Periodontol.
Somacarrera M.L.
65
671
1994
10.1902/jop.1994.65.7.671
Somacarrera ML, Hernández G, Acero J, Moskow BS.
Factors related to the incidence and severity of cyclosporin-induced gingival overgrowth in transplant patients. A longitudinal study.
J Periodontol
1994;
65
(7)
: 671-5.
a
J. Periodontol.
Somacarrera M.L.
65
666
1994
10.1902/jop.1994.65.7.666
Somacarrera ML, Hernández G, Acero J, Moskow BS.
Localization of gingival overgrowth in heart transplant patients undergoing cyclosporin therapy.
J Periodontol
1994;
65
(7)
: 666-70.
b
J. Periodontal Res.
Miranda J.
47
776
2012
10.1111/j.1600-0765.2012.01495.x
Miranda J, Brunet L, Roset P, Farré M, Mendieta C.
Reliability of two measurement indices for gingival enlargement.
J Periodontal Res
2012;
47
(6)
: 776-82.
J. Clin. Periodontol.
Majola M.P.
27
506
2000
10.1034/j.1600-051x.2000.027007506.x
Majola MP, McFadyen ML, Connolly C, Nair YP, Govender M, Laher MH.
Factors influencing phenytoin-induced gingival enlargement.
J Clin Periodontol
2000;
27
(7)
: 506-12.
Transplant. Proc.
Lima R.B.
40
1425
2008
10.1016/j.transproceed.2008.01.071
Lima RB, Benini V, Sens YA.
Gingival overgrowth in renal transplant recipients: A study concerning prevalence, severity, periodontal, and predisposing factors.
Transplant Proc
2008;
40
(5)
: 1425-8.
J. Periodontol.
Dill R.E.
68
375
1997
10.1902/jop.1997.68.4.375
Dill RE, Iacopino AM.
Myofibroblasts in phenytoin-induced hyperplastic connective tissue in the rat and in human gingival overgrowth.
J Periodontol
1997;
68
(4)
: 375-80.
J. Periodontal Res.
Ayanoglou C.M.
34
7
1999
10.1111/j.1600-0765.1999.tb02216.x
Ayanoglou CM, Lesty C.
Cyclosporin A-induced gingival overgrowth in the rat: A histological, ultrastructural and histomorphometric evaluation.
J Periodontal Res
1999;
34
(1)
: 7-15.
J. Oral Sci.
Castro L.A.
52
55
2010
10.2334/josnusd.52.55
Castro LA, Elias LS, Oton-Leite AF, et al.
Long-term effects of nifedipine on human gingival epithelium: A histopathological and immunohistochemical study.
J Oral Sci
2010;
52
(1)
: 55-62.
J. Periodontol.
Csiszar A.
78
304
2007
10.1902/jop.2007.060165
Csiszar A, Wiebe C, Larjava H, Häkkinen L.
Distinctive molecular composition of human gingival interdental papilla.
J Periodontol
2007;
78
(2)
: 304-14.
J. Oral Pathol.
Yamasaki A.
16
129
1987
10.1111/j.1600-0714.1987.tb01479.x
Yamasaki A, Rose GG, Pinero GJ, Mahan CJ.
Ultrastructure of fibroblasts in cyclosporin A-induced gingival hyperplasia.
J Oral Pathol
1987;
16
(3)
: 129-34.
Crit. Rev. Oral Biol. Med.
Lekic P.C.
8
253
1997
10.1177/10454411970080030201
Lekic PC, Pender N, McCulloch CA.
Is fibroblast heterogeneity relevant to the health, diseases, and treatments of periodontal tissues?
Crit Rev Oral Biol Med
1997;
8
(3)
: 253-68.
Arch. Oral Biol.
Fujii A.
39
99
1994
10.1016/0003-9969(94)90103-1
Fujii A, Matsumoto H, Nakao S, Teshigawara H, Akimoto Y.
Effect of calcium-channel blockers on cell proliferation, DNA synthesis and collagen synthesis of cultured gingival fibroblasts derived from human nifedipine responders and non-responders.
Arch Oral Biol
1994;
39
(2)
: 99-104.
J. Clin. Periodontol.
Dannewitz B.
33
510
2006
10.1111/j.1600-051X.2006.00937.x
Dannewitz B, Edrich C, Tomakidi P, et al.
Elevated levels of gene expression for collagen and decorin in human gingival overgrowth.
J Clin Periodontol
2006;
33
(7)
: 510-6.
J. Periodontol.
Kanno C.M.
79
114
2008
10.1902/jop.2008.070267
Kanno CM, Oliveira JA, García JF, Castro AL, Crivelini MM.
Effects of cyclosporin, phenytoin, and nifedipine on the synthesis and degradation of gingival collagen in tufted capuchin monkeys (Cebus apella): Histochemical and MMP-1 and -2 and collagen I gene expression analyses.
J Periodontol
2008;
79
(1)
: 114-22.
J. Oral Pathol.
Hassell T.M.
11
310
1982
10.1111/j.1600-0714.1982.tb00171.x
Hassell TM.
Evidence for production of an inactive collagenase by fibroblasts from phenytoin-enlarged human gingivae.
J Oral Pathol
1982;
11
(4)
: 310-7.
J. Cell. Physiol.
Kataoka M.
182
351
2000
10.1002/(SICI)1097-4652(200003)182:3<351::AID-JCP5>3.0.CO;2-U
Kataoka M, Shimizu Y, Kunikiyo K, et al.
Cyclosporin A decreases the degradation of type I collagen in rat gingival overgrowth.
J Cell Physiol
2000;
182
(3)
: 351-8.
J. Periodontol.
Hyland P.L.
74
437
2003
10.1902/jop.2003.74.4.437
Hyland PL, Traynor PS, Myrillas TT, et al.
The effects of cyclosporin on the collagenolytic activity of gingival fibroblasts.
J Periodontol
2003;
74
(4)
: 437-45.
J. Periodontal Res.
Sukkar T.Z.
42
580
2007
10.1111/j.1600-0765.2007.00986.x
Sukkar TZ, Thomason JM, Cawston TE, et al.
Gingival fibroblasts grown from cyclosporin-treated patients show a reduced production of matrix metalloproteinase-1 (MMP-1) compared with normal gingival fibroblasts, and cyclosporin down-regulates the production of MMP-1 stimulated by pro-inflammatory cytokines.
J Periodontal Res
2007;
42
(6)
: 580-8.
J. Periodontol.
Kataoka M.
72
1078
2001
10.1902/jop.2001.72.8.1078
Kataoka M, Shimizu Y, Kunikiyo K, et al.
Nifedipine induces gingival overgrowth in rats through a reduction in collagen phagocytosis by gingival fibroblasts.
J Periodontol
2001;
72
(8)
: 1078-83.
J. Periodontal Res.
Yamaguchi M.
39
320
2004
10.1111/j.1600-0765.2004.00746.x
Yamaguchi M, Naruishi K, Yamada-Naruishi H, Omori K, Nishimura F, Takashiba S.
Long-term cyclosporin A exposure suppresses cathepsin-B and -L activity in gingival fibroblasts.
J Periodontal Res
2004;
39
(5)
: 320-6.
J. Periodontol.
Kato T.
76
941
2005
10.1902/jop.2005.76.6.941
Kato T, Okahashi N, Kawai S, et al.
Impaired degradation of matrix collagen in human gingival fibroblasts by the antiepileptic drug phenytoin.
J Periodontol
2005;
76
(6)
: 941-50.
Oral Dis.
Kato T.
12
156
2006
10.1111/j.1601-0825.2005.01175.x
Kato T, Okahashi N, Ohno T, Inaba H, Kawai S, Amano A.
Effect of phenytoin on collagen accumulation by human gingival fibroblasts exposed to TNF-alpha in vitro.
Oral Dis
2006;
12
(2)
: 156-62.
Am. J. Pathol.
Sume S.S.
177
208
2010
10.2353/ajpath.2010.090952
Sume SS, Kantarci A, Lee A, Hasturk H, Trackman PC.
Epithelial to mesenchymal transition in gingival overgrowth.
Am J Pathol
2010;
177
(1)
: 208-18.
J. Periodontal Res.
Saito K.
31
545
1996
10.1111/j.1600-0765.1996.tb00519.x
Saito K, Mori S, Iwakura M, Sakamoto S.
Immunohistochemical localization of transforming growth factor beta, basic fibroblast growth factor and heparan sulphate glycosaminoglycan in gingival hyperplasia induced by nifedipine and phenytoin.
J Periodontal Res
1996;
31
(8)
: 545-55.
J. Periodontol.
Chen Y.T.
76
2267
2005
10.1902/jop.2005.76.12.2267
Chen YT, Tu HP, Chin YT, et al.
Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor gene and protein expression in cyclosporin-induced overgrown edentulous gingiva in rats.
J Periodontol
2005;
76
(12)
: 2267-75.
J. Cell Sci.
Matthay M.A.
106
869
1993
Matthay MA, Thiery JP, Lafont F, Stampfer F, Boyer B.
Transient effect of epidermal growth factor on the motility of an immortalized mammary epithelial cell line.
J Cell Sci
1993;
106
(Pt 3)
: 869-78.
J. Periodontol.
Chin Y.T.
77
647
2006
10.1902/jop.2006.050130
Chin YT, Chen YT, Tu HP, et al.
Upregulation of the expression of epidermal growth factor and its receptor in gingiva upon cyclosporin A treatment.
J Periodontol
2006;
77
(4)
: 647-56.
J. Periodontol.
Plemons J.M.
67
264
1996
10.1902/jop.1996.67.3.264
Plemons JM, Dill RE, Rees TD, Dyer BJ, Ng MC, Iacopino AM.
PDGF-B producing cells and PDGF-B gene expression in normal gingival and cyclosporine A-induced gingival overgrowth.
J Periodontol
1996;
67
(3)
: 264-70.
J. Clin. Periodontol.
Kasasa S.C.
25
640
1998
10.1111/j.1600-051X.1998.tb02500.x
Kasasa SC, Soory M.
The effect of PDGF, TGF-β and IGF in combination on androgen metabolism by fibroblasts.
J Clin Periodontol
1998;
25
(8)
: 640-6.
Crit. Rev. Oral Biol. Med.
Trackman P.C.
15
165
2004
10.1177/154411130401500305
Trackman PC, Kantarci A.
Connective tissue metabolism and gingival overgrowth.
Crit Rev Oral Biol Med
2004;
15
(3)
: 165-75.
J. Periodontol.
Uzel M.I.
72
921
2001
10.1902/jop.2001.72.7.921
Uzel MI, Kantarci A, Hong HH, et al.
Connective tissue growth factor in drug-induced gingival overgrowth.
J Periodontol
2001;
72
(7)
: 921-31.
J. Periodontal Res.
Walsh P.
42
144
2007
10.1111/j.1600-0765.2006.00927.x
Walsh P, Häkkinen L, Pernu H, Knuuttila M, Larjava H.
Expression of fibronectin-binding integrins in gingival epithelium in drug-induced gingival overgrowth.
J Periodontal Res
2007;
42
(2)
: 144-51.
J. Periodontal Res.
Kataoka M.
38
533
2003
10.1034/j.1600-0765.2003.00692.x
Kataoka M, Seto H, Wada C, Kido J, Nagata T.
Decreased expression of alpha2 integrin in fibroblasts isolated from cyclosporin A- induced gingival overgrowth in rats.
J Periodontal Res
2003;
38
(5)
: 533-7.
J. Dent. Res.
Häkkinen L.
86
25
2007
10.1177/154405910708600104
Häkkinen L, Csiszar A.
Hereditary gingival fibromatosis: Characteristics and novel putative pathogenic mechanisms.
J Dent Res
2007;
86
(1)
: 25-34.
J. Oral Pathol. Med.
Pagliarini A.
24
72
1995
10.1111/j.1600-0714.1995.tb01142.x
Pagliarini A, Stabellini G, Carinci F, Calura G, Tognon M, Evangelisti R.
Heterogeneity of fibroblasts derived from human free and attached gingiva. Glycosaminoglycan synthesis and effects of phenytoin (PHT) treatment.
J Oral Pathol Med
1995;
24
(2)
: 72-7.
Am. J. Respir. Cell Mol. Biol.
Zhang H.Y.
21
658
1999
10.1165/ajrcmb.21.6.3720
Zhang HY, Phan SH.
Inhibition of myofibroblast apoptosis by transforming growth factor beta(1).
Am J Respir Cell Mol Biol
1999;
21
(6)
: 658-65.
J. Cell. Biochem.
Tipton D.A.
46
152
1991
10.1002/jcb.240460209
Tipton DA, Stricklin GP, Dabbous MK.
Fibroblast heterogeneity in collagenolytic response to cyclosporine.
J Cell Biochem
1991;
46
(2)
: 152-65.
J. Clin. Periodontol.
Thomason J.M.
23
628
1996
10.1111/j.1600-051X.1996.tb00586.x
Thomason JM, Seymour RA, Ellis JS, et al.
Determinants of gingival overgrowth severity in organ transplant patients: An examination of the rôle of HLA phenotype.
J Clin Periodontol
1996;
23
(7)
: 628-34.
J. Periodontol.
Pernu H.E.
72
160
2001
10.1902/jop.2001.72.2.160
Pernu HE, Knuuttila ML.
Macrophages and lymphocyte subpopulations in nifedipine and cyclosporin A associated human gingival overgrowth.
J Periodontol
2001;
72
(2)
: 160-6.
J. Periodontol.
Bulut S.
73
892
2002
10.1902/jop.2002.73.8.892
Bulut S, Alaaddinoglu EE, Bilezikçi B, Demirhan B, Moray G.
Immunohistochemical analysis of lymphocyte subpopulations in cyclosporin A-induced gingival overgrowth.
J Periodontol
2002;
73
(8)
: 892-9.
Clin. Pharmacol. Ther.
Meisel P.
79
62
2006
10.1016/j.clpt.2005.09.008
Meisel P, Giebel J, Kunert-Keil C, Dazert P, Kroemer HK, Kocher T.
MDR1 gene polymorphisms and risk of gingival hyperplasia induced by calcium antagonists.
Clin Pharmacol Ther
2006;
79
(1)
: 62-71.
J. Periodontal Res.
De Iudicibus S.
43
665
2008
10.1111/j.1600-0765.2008.01068.x
De Iudicibus S, Castronovo G, Gigante A, et al.
Role of MDR1 gene polymorphisms in gingival overgrowth induced by cyclosporine in transplant patients.
J Periodontal Res
2008;
43
(6)
: 665-72.
Eur. J. Clin. Pharmacol.
García M.
69
385
2013
10.1007/s00228-012-1355-x
García M, Macías RM, Cubero JJ, Benítez J, Caravaca F, Gervasini G.
ABCB1 polymorphisms are associated with cyclosporine-induced nephrotoxicity and gingival hyperplasia in renal transplant recipients.
Eur J Clin Pharmacol
2013;
69
(3)
: 385-93.
J. Dent. Res.
Ogino M.
84
1183
2005
10.1177/154405910508401217
Ogino M, Kido J, Bando M, et al.
Alpha 2 integrin +807 polymorphism in drug-induced gingival overgrowth.
J Dent Res
2005;
84
(12)
: 1183-6.
J. Periodontol.
Hong H.H.
73
145
2002
10.1902/jop.2002.73.2.145
Hong HH, Trackman PC.
Cytokine regulation of gingival fibroblast lysyl oxidase, collagen, and elastin.
J Periodontol
2002;
73
(2)
: 145-52.
Growth Factors
Dreyfuss J.L.
28
24
2010
10.3109/08977190903321819
Dreyfuss JL, Veiga SS, Coulson-Thomas VJ, et al.
Differences in the expression of glycosaminoglycans in human fibroblasts derived from gingival overgrowths is related to TGF-beta up-regulation.
Growth Factors
2010;
28
(1)
: 24-33.
J. Dent. Res.
Kim S.S.
92
1022
2013
10.1177/0022034513503659
Kim SS, Jackson-Boeters L, Darling MR, Rieder MJ, Hamilton DW.
Nifedipine induces periostin expression in gingival fibroblasts through TGF-beta.
J Dent Res
2013;
92
(11)
: 1022-8.
J. Periodontol.
Cotrim P.
73
1313
2002
10.1902/jop.2002.73.11.1313
Cotrim P, de Andrade CR, Martelli-Junior H, Graner E, Sauk JJ, Coletta RD.
Expression of matrix metalloproteinases in cyclosporin-treated gingival fibroblasts is regulated by transforming growth factor (TGF)-β1 autocrine stimulation.
J Periodontol
2002;
73
(11)
: 1313-22.
J. Periodontol.
Cotrim P.
74
1625
2003
10.1902/jop.2003.74.11.1625
Cotrim P, Martelli-Junior H, Graner E, Sauk JJ, Coletta RD.
Cyclosporin A induces proliferation in human gingival fibroblasts via induction of transforming growth factor-β1.
J Periodontol
2003;
74
(11)
: 1625-33.
J. Cell. Biochem.
Heng E.C.
98
409
2006
10.1002/jcb.20810
Heng EC, Huang Y, Black SA Jr, Trackman PC.
CCN2, connective tissue growth factor, stimulates collagen deposition by gingival fibroblasts via module 3 and alpha6- and beta1 integrins.
J Cell Biochem
2006;
98
(2)
: 409-20.
Toxicol. Mech. Methods
Sardarian A.
25
98
2015
10.3109/15376516.2014.990595
Sardarian A, Andisheh Tadbir A, Zal F, et al.
Altered oxidative status and integrin expression in cyclosporine A-treated oral epithelial cells.
Toxicol Mech Methods
2015;
25
(2)
: 98-104.
Int. J. Biochem. Cell Biol.
Staudinger L.A.
62
80
2015
10.1016/j.biocel.2015.02.019
Staudinger LA, Spano SJ, Lee WS, Coelho N, Moriarty TJ, McCulloch CA.
Role of discoidin domain receptor 1 in dysregulation of collagen remodeling by cyclosporin A.
Int J Biochem Cell Biol
2015;
62
: 80-7.
Am. J. Pathol.
Nishimura F.
161
2047
2002
10.1016/S0002-9440(10)64483-5
Nishimura F, Naruishi H, Naruishi K, et al.
Cathepsin-L, A key molecule in the pathogenesis of drug-induced and I-cell disease-mediated gingival overgrowth: A study with cathepsin-L-deficient mice.
Am J Pathol
2002;
161
(6)
: 2047-52.
Oral Dis.
Brown R.S.
21
e51
2015
10.1111/odi.12264
Brown RS, Arany PR.
Mechanism of drug-induced gingival overgrowth revisited: A unifying hypothesis.
Oral Dis
2015;
21
(1)
: e51-61.
J. Oral Pathol. Med.
Stabellini G.
33
346
2004
10.1111/j.1600-0714.2004.00217.x
Stabellini G, Calastrini C, Mariani G, et al.
Extracellular glycosaminoglycan changes in healthy and overgrown gingiva fibroblasts after cyclosporin A and cytokine treatments.
J Oral Pathol Med
2004;
33
(6)
: 346-53.
J. Periodontal Res.
Gnoatto N.
42
553
2007
10.1111/j.1600-0765.2007.00981.x
Gnoatto N, Lotufo RF, Matsuda M, Penna V, Marquezini MV.
Expression of cell-surface heparan sulfate proteoglycans in human cyclosporin-induced gingival overgrowth.
J Periodontal Res
2007;
42
(6)
: 553-8.
J. Periodontal Res.
Flynn J.C.
41
316
2006
10.1111/j.1600-0765.2006.00864.x
Flynn JC, Henderson JS, Johnson RB.
Synergism between nifedipine and cyclosporine A on the incorporation of [35S] sulfate into human gingival fibroblast cultures in vitro.
J Periodontal Res
2006;
41
(4)
: 316-21.
Dent. Res. J.
Ponnaiyan D.
12
499
2015
10.4103/1735-3327.170546
Ponnaiyan D, Jegadeesan V, Cyclosporine A.
Novel concepts in its role in drug-induced gingival overgrowth. Review article.
Dent Res J
2015;
12
: 499-506.
Ramírez-Rámiz A.
Estudio celular y molecular en cultivos de fibroblastos tratados con fármacos inductores de agrandamiento gingival.
2007.
Available at: http://www.tdx.cat/handle/10803/689
Arch. Oral Biol.
Jung J.Y.
53
1042
2008
10.1016/j.archoralbio.2008.03.008
Jung JY, Jeong YJ, Jeong TS, Chung HJ, Kim WJ.
Inhibition of apoptotic signals in overgrowth of human gingival fibroblasts by cyclosporin A treatment.
Arch Oral Biol
2008;
53
(11)
: 1042-9.
J. Dent. Res.
Kantarci A.
86
888
2007
10.1177/154405910708600916
Kantarci A, Augustin P, Firatli E, et al.
Apoptosis in gingival overgrowth tissues.
J Dent Res
2007;
86
(9)
: 888-92.
Eur. J. Pharmacol.
Fujimori Y.
415
95
2001
10.1016/S0014-2999(01)00810-X
Fujimori Y, Maeda S, Saeki M, Morisaki I, Kamisaki Y.
Inhibition by nifedipine of adherence and activated macrophage-induced death of human gingival fibroblasts.
Eur J Pharmacol
2001;
415
(1)
: 95-103.
J. Periodontol.
Barber M.T.
63
397
1992
10.1902/jop.1992.63.5.397
Barber MT, Savage NW, Seymour GJ.
The effect of cyclosporin and lipopolysaccharide on fibroblasts: Implications for cyclosporin-induced gingival overgrowth.
J Periodontol
1992;
63
(5)
: 397-404.
J. Periodontal Res.
Bartold P.M.
27
499
1992
10.1111/j.1600-0765.1992.tb01823.x
Bartold PM, Narayanan AS, Page RC.
Platelet-derived growth factor reduces the inhibitory effects of lipopolysaccharide on gingival fibroblast proliferation.
J Periodontal Res
1992;
27
(5)
: 499-505.
J. Periodontal Res.
Birraux J.
41
297
2006
10.1111/j.1600-0765.2006.00873.x
Birraux J, Kirby JA, Thomason JM, Taylor JJ.
The effect of cyclosporin on cell division and apoptosis in human oral keratinocytes.
J Periodontal Res
2006;
41
(4)
: 297-302.
J. Periodontol.
Shimizu Y.
73
861
2002
10.1902/jop.2002.73.8.861
Shimizu Y, Kataoka M, Seto H, Kido J, Nagata T.
Nifedipine induces gingival epithelial hyperplasia in rats through inhibition of apoptosis.
J Periodontol
2002;
73
(8)
: 861-7.
Head Face Med.
Bulut S.
2
13
2006
10.1186/1746-160X-2-13
Bulut S, Uslu H, Özdemir BH, Bulut ÖE.
Analysis of proliferative activity in oral gingival epithelium in immunosuppressive medication induced gingival overgrowth.
Head Face Med
2006;
2
: 13-20.
J. Periodontol.
Nurmenniemi P.K.
72
167
2001
10.1902/jop.2001.72.2.167
Nurmenniemi PK, Pernu HE, Knuuttila ML.
Mitotic activity of keratinocytes in nifedipine and immunosuppressive medication-induced gingival overgrowth.
J Periodontol
2001;
72
(2)
: 167-73.
J. Periodontol.
Das S.J.
72
745
2001
10.1902/jop.2001.72.6.745
Das SJ, Parkar MH, Olsen I.
Upregulation of keratinocyte growth factor in cyclosporin A-induced gingival overgrowth.
J Periodontol
2001;
72
(6)
: 745-52.
J. Periodontol.
Tamilselvan S.
78
290
2007
10.1902/jop.2007.060172
Tamilselvan S, Raju SN, Loganathan D, Kamatchiammal S, Abraham G, Suresh R.
Endothelin-1 and its receptors ET(A) and ET(B) in drug-induced gingival overgrowth.
J Periodontol
2007;
78
(2)
: 290-5.
J. Periodontol.
Gürkan A.
80
1638
2009
10.1902/jop.2009.090138
Gürkan A, Emingil G, Öktem G, et al.
Immunohistochemical analysis of inducible and endothelial forms of nitric oxide synthase in cyclosporin A-induced gingival overgrowth.
J Periodontol
2009;
80
(10)
: 1638-47.
J. Periodontol.
Lee S.S.
84
1469
2013
10.1902/jop.2012.120554
Lee SS, Tsai CH, Kuan YH, Huang FM, Chang YC.
The upregulation of transglutaminase-2 by cyclosporin A in human gingival fibroblasts is augmented by oxidative stress.
J Periodontol
2013;
84
(10)
: 1469-75.
Front. Cell. Infect. Microbiol.
Sukuroglu E.
5
87
2015
10.3389/fcimb.2015.00087
Sukuroglu E, Güncü GN, Kilinc K, Caglayan F.
Using salivary nitrite and nitrate levels as a biomarker for drug-induced gingival overgrowth.
Front Cell Infect Microbiol
2015;
5
: 87.
Semin. Liver Dis.
Copple B.L.
30
195
2010
10.1055/s-0030-1253228
Copple BL, Jaeschke H, Klaassen CD.
Oxidative stress and the pathogenesis of cholestasis.
Semin Liver Dis
2010;
30
(2)
: 195-204.
J. Periodontol.
Nurmenniemi P.K.
75
933
2004
10.1902/jop.2004.75.7.933
Nurmenniemi PK, Pernu HE, Knuuttila ML.
Mast cell subpopulations in gingival overgrowth induced by immunosuppressive and nifedipine medication.
J Periodontol
2004;
75
(7)
: 933-8.
J. Clin. Diagn. Res.
Balaji A.
9
ZC92
2015
Balaji A, Balaji TM, Rao SR.
Angiotensin II levels in gingival tissues from healthy individuals, patients with nifedipine induced gingival overgrowth and non responders on nifedipine.
J Clin Diagn Res
2015;
9
(8)
: ZC92-4.
Comp. Biochem. Physiol. C Toxicol. Pharmacol.
Ohuchi N.
132
451
2002
10.1016/S1532-0456(02)00098-4
Ohuchi N, Koike K, Sano M, et al.
Proliferative effects of angiotensin II and endothelin-1 on guinea pig gingival fibroblast cells in culture.
Comp Biochem Physiol C Toxicol Pharmacol
2002;
132
(4)
: 451-60.
J. Periodontal Res.
Subramani T.
48
386
2013
10.1111/jre.12020
Subramani T, Senthilkumar K, Periasamy S, Rao S.
Expression of angiotensin II and its receptors in cyclosporine-induced gingival overgrowth.
J Periodontal Res
2013;
48
(3)
: 386-91.
J. Clin. Invest.
Wynn T.A.
117
524
2007
10.1172/JCI31487
Wynn TA.
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases.
J Clin Invest
2007;
117
(3)
: 524-9.
J. Dent. Res.
Trackman P.C.
94
540
2015
10.1177/0022034515571265
Trackman PC, Kantarci A.
Molecular and clinical aspects of drug-induced gingival overgrowth.
J Dent Res
2015;
94
(4)
: 540-6.
J. Periodontol.
Nares S.
67
271
1996
10.1902/jop.1996.67.3.271
Nares S, Ng MC, Dill RE, Park B, Cutler CW, Iacopino AM.
Cyclosporine A upregulates platelet-derived growth factor B chain in hyperplastic human gingiva.
J Periodontol
1996;
67
(3)
: 271-8.
J. Periodontol.
Nurmenniemi P.K.
73
1323
2002
10.1902/jop.2002.73.11.1323
Nurmenniemi PK, Pernu HE, Laukkanen P, Knuuttila ML.
Macrophage subpopulations in gingival overgrowth induced by nifedipine and immunosuppressive medication.
J Periodontol
2002;
73
(11)
: 1323-30.
J. Periodontol.
Iacopino A.M.
68
73
1997
10.1902/jop.1997.68.1.73
Iacopino AM, Doxey D, Cutler CW, et al.
Phenytoin and cyclosporine A specifically regulate macrophage phenotype and expression of platelet-derived growth factor and interleukin-1 in vitro and in vivo: possible molecular mechanism of drug-induced gingival hyperplasia.
J Periodontol
1997;
68
(1)
: 73-83.
Br. J. Pharmacol.
Modéer T.
106
574
1992
10.1111/j.1476-5381.1992.tb14377.x
Modéer T, Brunius G, Iinuma M, Lerner UH.
Phenytoin potentiates interleukin-1-induced prostaglandin biosynthesis in human gingival fibroblasts.
Br J Pharmacol
1992;
106
(3)
: 574-8.
J. Periodontal Res.
Chiang C.Y.
42
443
2007
10.1111/j.1600-0765.2006.00967.x
Chiang CY, Chen YT, Hung FM, Tu HP, Fu MM, Fu E.
Cyclosporin-A inhibits the expression of cyclooxygenase-2 in gingiva.
J Periodontal Res
2007;
42
(5)
: 443-9.
J. Periodontal Res.
Nell A.
31
131
1996
10.1111/j.1600-0765.1996.tb00474.x
Nell A, Matejka M, Solar P, Ulm C, Sinzinger H.
Evidence that cyclosporine inhibits periodontal prostaglandin I2 synthesis.
J Periodontal Res
1996;
31
(2)
: 131-4.
J. Clin. Periodontol.
Czuszak C.A.
23
635
1996
10.1111/j.1600-051X.1996.tb00587.x
Czuszak CA, Sutherland DE, Billman MA, Stein SH.
Prostaglandin E2 potentiates interleukin-1 β induced interleukin-6 production by human gingival fibroblasts.
J Clin Periodontol
1996;
23
(7)
: 635-40.
Oral Dis.
Sakaki H.
10
87
2004
10.1046/j.1354-523X.2003.00982.x
Sakaki H, Matsumiya T, Kusumi A, et al.
Interleukin-1beta induces matrix metalloproteinase-1 expression in cultured human gingival fibroblasts: role of cyclooxygenase-2 and prostaglandin E2.
Oral Dis
2004;
10
(2)
: 87-93.
J. Cell Biol.
Wipff P.J.
179
1311
2007
10.1083/jcb.200704042
Wipff PJ, Rifkin DB, Meister JJ, Hinz B.
Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix.
J Cell Biol
2007;
179
(6)
: 1311-23.
Eur. J. Orthod.
Capelli J.
33
705
2011
10.1093/ejo/cjq148
Capelli J Jr, Kantarci A, Haffajee A, Teles RP, Fidel R Jr, Figueredo CM.
Matrix metalloproteinases and chemokines in the gingival crevicular fluid during orthodontic tooth movement.
Eur J Orthod
2011;
33
(6)
: 705-11.
Rom. J. Morphol. Embryol.
Şurlin P.
53
161
2012
Şurlin P, Rauten AM, Pirici D, Oprea B, Mogoantă L, Camen A.
Collagen IV and MMP-9 expression in hypertrophic gingiva during orthodontic treatment.
Rom J Morphol Embryol
2012;
53
(1)
: 161-5.
Rom. J. Morphol. Embryol.
Surlin P.
51
515
2010
Surlin P, Rauten AM, Mogoantă L, Siloşi I, Oprea B, Pirici D.
Correlations between the gingival crevicular fluid MMP8 levels and gingival overgrowth in patients with fixed orthodontic devices.
Rom J Morphol Embryol
2010;
51
(3)
: 515-9.
J. Can. Dent. Assoc.
Khoori A.H.
69
236
2003
Khoori AH, Einollahi B, Ansari G, Moozeh MB.
The effect of cyclosporine with and without nifedipine on gingival overgrowth in renal transplant patients.
J Can Dent Assoc
2003;
69
(4)
: 236-41.
J. Clin. Periodontol.
Thomason J.M.
32
273
2005
10.1111/j.1600-051X.2005.00657.x
Thomason JM, Seymour RA, Ellis JS.
Risk factors for gingival overgrowth in patients medicated with ciclosporin in the absence of calcium channel blockers.
J Clin Periodontol
2005;
32
(3)
: 273-9.
J. Periodontol.
Lin Y.T.
81
1250
2010
10.1902/jop.2010.090743
Lin YT, Yang FT.
Gingival enlargement in children administered cyclosporine after liver transplantation.
J Periodontol
2010;
81
(9)
: 1250-5.
Oral Surg. Oral Med. Oral Pathol. Oral Radiol.
Jiang L.
116
447
2013
10.1016/j.oooo.2013.06.021
Jiang L, Gao MJ, Zhou J, Zhao J, Zhao SW, Zhao YF.
Serum cyclophilin A concentrations in renal transplant recipients receiving cyclosporine A: Clinical implications for gingival overgrowth.
Oral Surg Oral Med Oral Pathol Oral Radiol
2013;
116
(4)
: 447-54.
J. Clin. Periodontol.
Ellis J.S.
31
863
2004
10.1111/j.1600-051X.2004.00572.x
Ellis JS, Morgan CL, Kirby JA, Taylor JJ, Thomason JM.
Plasma TGF-β1 as a risk factor for gingival overgrowth.
J Clin Periodontol
2004;
31
(10)
: 863-8.
J. Clin. Periodontol.
Radwan-Oczko M.
35
371
2008
10.1111/j.1600-051X.2008.01216.x
Radwan-Oczko M, Boratyńska M, Zietek M, Dobosz T.
Transforming growth factor-beta1 gene expression and cyclosporine A-induced gingival overgrowth: A pilot study.
J Clin Periodontol
2008;
35
(5)
: 371-8.